Cargando…
Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
• Clinical signs are not useful for detecting DVT in critically ill COVID-19 patients; • DVT occurs despite full dose anticoagulation in critically ill COVID-19 patients; • Severe COVID-19 patients present a high prevalence of bilateral DVT.
Autores principales: | Torres-Machorro, Adriana, Anguiano-Álvarez, Victor Manuel, Grimaldo-Gómez, Flavio Adrian, Rodríguez-Zanella, Hugo, Cortina de la Rosa, Evelyn, Mora-Canela, Sergio, Lerma, Claudia, García-Cruz, Edgar, Ramos-Enriquez, Ángel, Ramirez-Marroquin, Samuel, Izaguirre-Ávila, Raúl, Rojas-Velasco, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462642/ https://www.ncbi.nlm.nih.gov/pubmed/32927400 http://dx.doi.org/10.1016/j.thromres.2020.08.043 |
Ejemplares similares
-
Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit
por: Vlot, E.A., et al.
Publicado: (2020) -
Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
por: Bosch, Floris T.M., et al.
Publicado: (2021) -
Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
por: Lawlor, Matthew, et al.
Publicado: (2021) -
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020) -
Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)